Anxiety Medication Overview of Sinequan

The antidepressant doxepin (originally marketed by Pfizer under the brand name Sinequan) is a tricyclic antidepressant approved to treat anxiety disorders. As a medication in this class, doxepin (Sinequan) has a number of possible side effects. Not all people who take the medication will experience side effects, and the duration and severity can also vary between individuals.

Common Side Effects

The most common side effects of doxepin include drowsiness, dizziness or lightheadedness, nausea, constipation, difficulty urinating, dry mouth, weight gain, changes in libido or sexual function, changes in blood sugar levels, and excess sweating.

Serious Side Effects

Severe side effects are rare, but if they occur require immediate medical attention. Serious side effects of doxepin use may include allergic reaction, behavior changes, abnormal thoughts, fainting, hallucinations, sore throat or fever, mood changes, difficulty speaking and swallowing, chest pain, seizures, twitching of the face or tongue, a heartbeat that is fast, slow or irregular, unusual bleeding and bruising, jaundice, and suicidal thoughts.

While many people tolerate doxepin well, it is impossible to know beforehand whether you will experience side effects while taking the medication. Any side effects that are serious or bothersome should be reported to your doctor, so your doxepin dosage can be adjusted or the medication can be discontinued if necessary.

Photo: Pexels

More Articles

This article was written for Living With Anxiety by Sam Kaplan, a student at Colby College. This is his story of life with a panic disorder....

I subscribe to the Psychotherapy Networker e-newsletter and just read a great article by Nancy Errebo, Psy. D., about using EMDR with a returning...

Getting on an airplane can cause an anxiety attack even for the most seasoned flier. Whether it’s a fear of heights, the feeling of the unknown,...

According to Oliver Robinson and colleagues at the University of Greenwich in London, young adults between the ages of 25 and 35 are vulnerable to...

A team of neuroscientists from the New School for Social Research in New York has announced that not only are the areas of the brain responsible...

SITEMAP